Search Results for: stem cell biotech

Weekend reads: reversing death of pig brain cells, brain-gut stem cell link, plant stem cells, & more

pig-brain-fighting-death

It’s been a cool week for stem cell and other associated kinds of research. In this post I have a series of links to a variety of interesting developments and papers. Gene therapy cures bubble boy infants. William Wan over at the WaPo on this good news. Nope, this wasn’t done with CRISPR, but rather […]

Weekend reads: reversing death of pig brain cells, brain-gut stem cell link, plant stem cells, & more Read More »

Stem cell good news: novel cancer work, new CA bills, Alzheimer’s, & more pubs

stem-cells-alzheimers

There’s nothing like stem cell good news and interesting publications to perk one up on a Monday. Enjoy. What recent papers have struck you as exciting? Novel stem cell-based cancer approaches (Part 1) It was exciting when Fate Therapeutics got the first induced pluripotent stem cell (IPSC) IND in the U.S. for their IPSC-derived natural killer cell

Stem cell good news: novel cancer work, new CA bills, Alzheimer’s, & more pubs Read More »

Stem cell & regenerative medicine meetings for you to go to in 2019

Stem-Cell-Meetings-2019

I keep a yearly hub of stem cell & regenerative medicine meetings here on The Niche. Below I’ve pasted the list for 2019, which continues to grow. If you don’t see yours listed, send me an email with the info including a link (knoepflerATucdavisDOTedu). These meeting listings are not endorsements and I try to make

Stem cell & regenerative medicine meetings for you to go to in 2019 Read More »

FDA recalls Liveyon stem cell product: blow to big clinic supplier?

LIVEYON

The FDA has issued a recall of the main stem cell product of a California firm called Liveyon that is linked to unproven stem cell clinics. The recall seems to have been due to “adverse reactions.” An emerging big player in the birth-related stem cell clinic area? I’ve been hearing the name Liveyon pop up

FDA recalls Liveyon stem cell product: blow to big clinic supplier? Read More »

Quick Q&A with ViaCyte CEO on CRISPR-stem cell work

VC-01-post-implant-final1-e1503703572933, viacyte

We heard this week about the encouraging news of a new CRISPR-stem cell collaboration between stem cell biotech ViaCyte and CRISPR Therapeutics. The goal of the team is to make genetically engineered pancreatic derivatives from stem cells that would have a unique immune stealthiness. If such an approach was successful, patients would not need to

Quick Q&A with ViaCyte CEO on CRISPR-stem cell work Read More »

Stem cell news bites: Astellas trial, cystic fibrosis claim, a few cool papers

Matoba-et-al-Figure-2c-2018

Stem cell news is always burbling up, sometimes right there in front of us on the web and other times via networks of people. Astellas news. Some may remember there used to be this pioneering stem cell biotech called ACT, which then became Ocata, and finally was acquired by the big company Astellas. One of

Stem cell news bites: Astellas trial, cystic fibrosis claim, a few cool papers Read More »